Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

Schultz, L. M., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A. K., … Laetsch, T. W. (2022). Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of Clinical Oncology, 40(9), 945–955. https://doi.org/10.1200/jco.20.03585
Authors:
Liora M. Schultz
Valentin V. Barsan
Christina Baggott
Michael Kunicki
Sharon Mavroukakis
Emily Egeler
Snehit Prabhu
Holly L. Pacenta
Theodore W. Laetsch
Christine L. Phillips
Christa Krupski
Jenna Rossoff
Heather E. Stefanski
Vasant Chinnabhandar
Julie-An Talano
Amy Moskop
Steven P. Margossian
Michael R. Verneris
Amy K. Keating
Gary Douglas Myers
Rachel Wilcox
Nicole A. Karras
Patrick A. Brown
Muna Qayed
Michelle Hermiston
A. Yasemin Goksenin
Prakash Satwani
Cara A. Rabik
Vanessa A. Fabrizio
Kevin J. Curran
Rayne H. Rouce
Yimei Li
Crystal L. Mackall
Affiliated Authors:
Prakash Satwani
Columbia Affiliation:
Subjects:
Leukemia, Lymphocytic, Chronic, B-Cell (MeSH)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (MeSH)
Receptors, Chimeric Antigen (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1200/JCO.20.03585
PMID:
34882493
DOI:
10.1200/JCO.20.03585
Journal:
Journal of Clinical Oncology
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record
View PubMed Record

Record Created: